ADTX Aditxt, Inc.

Nasdaq aditxt.com


$ 2.89 $ -0.51 (-14.91 %)    

Thursday, 20-Nov-2025 15:43:21 EST
QQQ $ 586.19 $ -25.47 (-4.16 %)
DIA $ 458.47 $ -8.21 (-1.76 %)
SPY $ 653.35 $ -19.55 (-2.91 %)
TLT $ 89.29 $ 0.30 (0.33 %)
GLD $ 374.77 $ -0.41 (-0.11 %)
$ 3.48
$ 3.42
$ 2.88 x 250
$ 2.89 x 3
$ 2.89 - $ 3.42
$ 3.48 - $ 11,941.28
170,659
na
152,480
$ 2.38
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-17-2025 09-30-2025 10-Q
2 08-14-2025 06-30-2025 10-Q
3 05-15-2025 03-31-2025 10-Q
4 03-31-2025 12-31-2024 10-K
5 11-18-2024 09-30-2024 10-Q
6 08-19-2024 06-30-2024 10-Q
7 05-20-2024 03-31-2024 10-Q
8 04-16-2024 12-31-2023 10-K
9 11-14-2023 09-30-2023 10-Q
10 08-14-2023 06-30-2023 10-Q
11 05-15-2023 03-31-2023 10-Q
12 04-17-2023 12-31-2022 10-K
13 11-14-2022 09-30-2022 10-Q
14 08-15-2022 06-30-2022 10-Q
15 05-16-2022 03-31-2022 10-Q
16 03-31-2022 12-31-2021 10-K
17 11-15-2021 09-30-2021 10-Q
18 08-12-2021 06-30-2021 10-Q
19 05-12-2021 03-31-2021 10-Q
20 03-25-2021 12-31-2020 10-K
21 11-13-2020 09-30-2020 10-Q
22 08-13-2020 06-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 aditxts-pearsanta-begins-enrollment-in-clinical-study-evaluating-mitomic-endometriosis-test-blood-based-diagnostic-designed-to-aid-in-early-detection-of-endometriosis

Prospective study to evaluate diagnostic performance and generate real-world data for the Mitomic® Endometriosis Test, a non-in...

Core News & Articles

-- Special Meeting to be held on September 26, 2025 --SAN DIEGO, Sept. 9, 2025 /PRNewswire/ -- In an update to stockholders tod...

 aditxt-plans-fda-submission-for-first-in-human-trials-in-type-1-diabetes-and-stiff-person-syndrome-in-early-2026

Plans to seek FDA submission and approval for first-in-human trials in type 1 diabetes and stiff person syndrome targeted for e...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION